The expression and activity of glutamate transporters [excitatory amino acid transporters (EAAT) 1 and EAAT2] have been reported to be significantly decreased in both glioma cell lines and fresh glioma tissues (the ability to transport glutamate was only 1/100 in the physiological state) (35). This evidence concerns the gene SLC1A2 and central nervous system cancer.